Overall, the findings of this study that the Innomed 1 and Innomed 2 BCTs are highly effective in clinical use and are suitable for measuring glucose levels, HbA1c, thyroid hormones (such as thyroid stimulating hormone, free triiodothyronine, free thyroxine, and triiodothyronine), and tumor markers, including prostate-specific antigen and carcinoembryonic antigen. Here, KLK3 is linked to neoplasm.